Pathstone Holdings »

Prime Medicine shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $56k 14k 3.87

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Coca-Cola Company (KO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Prime Medicine

Alphabet
Vanguard Group
ARK Investment Management
BlackRock
BlackRock
T. Rowe Price Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
MWG Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Vestal Point Capital
Baker Bros. Advisors

View all funds holding Prime Medicine